Current role
Joseph M. Fitzgerald
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Joseph M. Fitzgerald
Joseph M. Fitzgerald is recorded as Board Member at Chain Bridge Bancorp Inc (CBNA). The proxy statement of Boston Scientific Corp reports total compensation of $8,042,997 for Joseph M. Fitzgerald in fiscal 2025, including a base salary of $892,604. Disclosed compensation is on record for 9 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Boston Scientific Corp (BSX)
Proxy statement
CurrentStart not stated–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Boston Scientific Corp
Other people whose current roles at this company are on record from its filings.
- Michael Mahoney CEO
- Jonathan Monson CFO
- Jodi Euerle Eddy CIO
- Desiree Ralls-Morrison General Counsel
- Vance R. Brown General Counsel
- Emily Woodworth (Collins) Chief Accounting Officer
- Catherine R. Smith Board Member
- Cheryl Pegus Board Member
- Cheryl Pegus, MD, MPH Board Member
- Christophe P. Weber Board Member
Leadership on record at Chain Bridge Bancorp Inc
Other people whose current roles at this company are on record from its filings.
- John J. Brough CEO
- Joanna R. Williamson CFO
- Andrew J. Fitzgerald Board Member
- Benita Thompson-Byas Board Member
- David M. Evinger Board Member
- John J. Brough II Board Member
- Leigh-Alexandra Basha Board Member
- Mark Martinelli Board Member
- Michael J. Conover Board Member
- Michelle L. Korsmo Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Boston Scientific Corp (BSX) | Executive Vice President and Group President, Cardiovascular | $892,604 | $8,042,997 |
| 2024 | Boston Scientific Corp (BSX) | Executive Vice President and Group President, Cardiology | $842,360 | $6,335,804 |
| 2023 | Boston Scientific Corp (BSX) | Executive Vice President and Group President, Cardiology | $793,560 | $5,592,519 |
| 2022 | Boston Scientific Corp (BSX) | Executive Vice President and Group President, Cardiology | $740,178 | $4,764,586 |
| 2021 | Boston Scientific Corp (BSX) | Executive Vice President and Group President, Cardiology | $699,130 | $4,309,535 |
| 2020 | Boston Scientific Corp (BSX) | Executive Vice President and Group President, Cardiology | $568,679 | $4,598,333 |
| 2019 | Boston Scientific Corp (BSX) | Executive Vice President and President, Interventional Cardiology | $667,416 | $4,025,457 |
| 2018 | Boston Scientific Corp (BSX) | Executive Vice President and President, Interventional Cardiology | $639,958 | $4,036,318 |
| 2017 | Boston Scientific Corp (BSX) | Executive Vice President and President, Rhythm Management | $564,740 | $5,838,997 |
Recent activity
No call appearances or filed executive changes recorded yet.